Constitutive expression of the steroid sulfatase gene supports the growth of MCF-7 human breast cancer cells in vitro and in vivo.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Endocrinology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/en.142.4.1497PMID 11250930
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estrogen sulfates: Biological and ultrastructural responses and metabolism in MCF-7 human breast cancer cells

  2005cited by this paper
• Human breast cancer cell line xenografts as models of breast cancer — The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines

  2005cited by this paper
• First generation aromatase inhibitors — aminoglutethimide and testololactone

  2004cited by this paper
• The effect of combining aromatase inhibitors with antiestrogens on tumor growth in a nude mouse model for breast cancer

  1999cited by this paper
• Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium.

  1999cited by this paper
• Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cells.

  1998cited by this paper
• Aromatase in the normal breast and breast cancer.

  1997cited by this paper
• Issues in experimental design and endpoint analysis in the study of experimental cytotoxic agents in vivo in breast cancer and other models

  1997cited by this paper
• Mechanism for maintenance of high breast tumor estradiol concentrations in the absence of ovarian function: Role of very high affinity tissue uptake

  1997cited by this paper
• Future uses for aromatase inhibitors in breast cancer.

  1997cited by this paper
• Control and expression of oestrone sulphatase activities in human breast cancer.

  1996cited by this paper
• Acquired estrogen independence and antiestrogen resistance in breast cancer: estrogen receptor driven phenotypes?

  1996cited by this paper
• Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines.

  1996cited by this paper
• Effect of nomegestrol acetate on estrone-sulfatase and 17beta-hydroxysteroid dehydrogenase activities in human breast cancer cells.

  1996cited by this paper
• Estrogens, phytoestrogens, and breast cancer.

  1996cited by this paper
• Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients.

  1996cited by this paper
• Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells.

  1995cited by this paper
• Breast cancer and expression of aromatase in breast adipose tissue.

  1994cited by this paper
• Effect of the progestagen Promegestone (R-5020) on mRNA of the oestrone sulphatase in the MCF-7 human mammary cancer cells.

  1994cited by this paper
• Intratumoral oestrone sulphatase activity as a prognostic marker in human breast carcinoma.

  1994cited by this paper
• Detection of breast cancer-associated estrone sulfatase in breast cancer biopsies and cell lines using polymerase chain reaction.

  1993cited by this paper
• Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate: a potential therapeutic agent in breast cancer.

  1993cited by this paper
• Differential estrogen substrate specificities for transiently expressed human placental 17 beta-hydroxysteroid dehydrogenase and an endogenous enzyme expressed in cultured COS-m6 cells.

  1993cited by this paper
• Estrone sulfate promotes human breast cancer cell replication and nuclear uptake of estradiol in MCF‐7 cell cultures

  1993cited by this paper
• Prognostic significance of aromatase and estrone sulfatase enzymes in human breast cancer.

  1993cited by this paper
• Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications.

  1993cited by this paper
• Recent data on estrogen sulfatases and sulfotransferases activities in human breast cancer.

  1992cited by this paper
• Prognostic value of breast cancer aromatase

  1992cited by this paper
• 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO.

  1991cited by this paper
• Estrone sulfatase activity and effect of antiestrogens on transformation of estrone sulfate in hormone-dependent vs. independent human breast cancer cell lines

  1991cited by this paper
• Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer.

  1990cited by this paper
• Estrone sulfate stimulates growth of nitrosomethylurea‐induced breast carcinoma in vivo in the rat

  1990cited by this paper
• Reduction of the membrane fluidity of human breast cancer cells by tamoxifen and 17 beta-estradiol.

  1990cited by this paper
• The inter-relationships between ovarian-independent growth, tumorigenicity, invasiveness and antioestrogen resistance in the malignant progression of human breast cancer.

  1989cited by this paper
• Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo.

  1989cited by this paper
• The effects of a constitutive expression of transforming growth factor-alpha on the growth of MCF-7 human breast cancer cells in vitro and in vivo.

  1989cited by this paper
• Alterations in the production rate and the metabolism of oestrone and oestrone sulphate in breast cancer patients treated with aminoglutethimide.

  1989cited by this paper
• Covalent binding of 17β-estradiol and retinoic acid to proteins in the human breast cancer cell line MCF-7

  1989cited by this paper
• Treatment of breast cancer with aromatase inhibitors--current status and future prospects.

  1989cited by this paper
• The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells.

  1988cited by this paper
• Safe and efficient ecotropic and amphotropic packaging lines for use in gene transfer experiments.

  1988cited by this paper
• Cloning and expression of steroid sulfatase cDNA and the frequent occurrence of deletions in STS deficiency: implications for X-Y interchange.

  1987cited by this paper
• Steroid sequestration and tightly bound oestrogen-protein complexes in human breast tumours and a breast cancer cell line.

  1986cited by this paper
• Aromatase, 17 beta-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women.

  1986cited by this paper
• A comparison of the in vivo uptake and metabolism of 3H‐oestrone and 3H‐oestradiol by normal breast and breast tumour tissues in post‐menopausal women

  1986cited by this paper
• Serum steroid levels in intact and endocrine ablated BALB/c nude mice and their intact littermates.

  1986cited by this paper
• Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue.

  1985cited by this paper
• New assay for steroid sulfatase (EC 3.1.6.2) and its application for studies of human placental and skin sulfatase.

  1984cited by this paper
• In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway.

  1984cited by this paper
• Effect of estradiol on human breast cancer cells in culture.

  1983cited by this paper
• Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice.

  1983cited by this paper
• A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis.

  1983cited by this paper
• Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells.

  1983cited by this paper
• A correlation between estrogen sulfotransferase levels and estrogen receptor status in human primary breast carcinoma.

  1979cited by this paper
• Prolonged retention of estradiol by human breast cancer cells in tissue culture.

  1979cited by this paper
• Estrone and estradiol content in human breast tumors: relationship to estradiol receptors.

  1977cited by this paper
• Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.

  1966cited by this paper

• Dysregulated androgen synthesis and anti-androgen resistance in advanced prostate cancer.

  2021cites this paper
• Design and synthesis of 3-benzylaminocoumarin-7-O-sulfamate derivatives as steroid sulfatase inhibitors.

  2020cites this paper
• Steroid Sulfatase Stimulates Intracrine Androgen Synthesis and is a Therapeutic Target for Advanced Prostate Cancer

  2020cites this paper
• Inhibition of DNA Repair Pathways and Induction of ROS Are Potential Mechanisms of Action of the Small Molecule Inhibitor BOLD-100 in Breast Cancer

  2020cites this paper
• Identification of mutagenic and endocrine disrupting compounds in surface water and wastewater treatment plant effluents using high-resolution effect-directed analysis.

  2019cites this paper
• Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer

  2017cites this paper
• Endocrine resistance in breast cancer--An overview and update.

  2015cites this paper
• Possible role of the aromatase-independent steroid metabolism pathways in hormone responsive primary breast cancers

  2013cites this paper
• Hormonal enzymatic systems in normal and cancerous human breast: control, prognostic factors, and clinical applications

  2012cites this paper
• Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers.

  2012cites this paper
• Distinct Genetic Alterations in Colorectal Cancer

  2010cites this paper
• Reductive 17beta-hydroxysteroid dehydrogenases in the sulfatase pathway: critical in the cell proliferation of breast cancer.

  2009cites this paper
• Recent developments of steroid sulfatase inhibitors as anti-cancer agents.

  2008cites this paper
• Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation.

  2008cites this paper
• Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer

  2008cites this paper
• Steroid metabolism in breast cancer.

  2008cites this paper
• Inhibition of steroid sulfatase activity and cell proliferation in ZR-75-1 and BT-474 human breast cancer cells by KW-2581 in vitro and in vivo

  2007cites this paper
• A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models

  2007cites this paper
• Estrogen receptor alpha positive breast tumors and breast cancer cell lines share similarities in their transcriptome data structures.

  2006cites this paper
• In vivo Efficacy of STX213, A Second-Generation Steroid Sulfatase Inhibitor, for Hormone-Dependent Breast Cancer Therapy

  2006cites this paper
• The role of X-linked genes in breast cancer

  2005cites this paper
• Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis.

  2005cites this paper
• Antiestrogens, aromatase inhibitors, and apoptosis in breast cancer.

  2005cites this paper
• Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.

  2005cites this paper
• Steroid sulfatase: molecular biology, regulation, and inhibition.

  2005cites this paper
• Development of novel steroid sulfatase inhibitors; II. TZS-8478 potently inhibits the growth of breast tumors in postmenopausal breast cancer model rats.

  2004cites this paper
• Role of enzymes and tissue-specific actions of steroids.

  2004cites this paper
• Pharmacokinetics of the nonsteroidal steroid sulphatase inhibitor 667 COUMATE and its sequestration into red blood cells in rats

  2004cites this paper
• High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer.

  2003cites this paper
• Novel Perspective: Focusing on the X Chromosome in Reproductive Cancers

  2003cites this paper
• Steroidal oxathiazine inhibitors of estrone sulfatase.

  2003cites this paper
• Regulation of MCF-7 breast cancer cell growth by beta-estradiol sulfation.

  2002cites this paper
• Effect of tibolone (Org OD14) and its metabolites on aromatase and estrone sulfatase activity in human breast adipose stromal cells and in MCF-7 and T47D breast cancer cells.

  2002cites this paper
• Proteomics for studying cancer cells and the development of chemoresistance

  2001cites this paper
• Tibolone: a compound with tissue specific inhibitory effects on sulfatase.

  2001cites this paper